ABVC BIOPHARMA, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Abvc Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
Abvc Biopharma, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$977K, a 55.5% increase year-over-year.
Abvc Biopharma, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$8.54M, a 22% increase year-over-year.
Abvc Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$8.22M, a 45.6% increase from 2022.
Abvc Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$15.1M, a 29.1% decline from 2021.
Abvc Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$11.7M, a 37.6% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$8.54M	-$977K	+$1.22M	+55.5%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	-$9.75M	-$3.44M	-$1.54M	-80.7%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-17
Q4 2023	-$8.22M	-$1.96M	+$1.17M	+37.4%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-13
Q3 2023	-$9.39M	-$2.15M	+$1.56M	+42%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-15
Q2 2023	-$10.9M	-$2.19M	-$147K	-7.18%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-14
Q1 2023	-$10.8M	-$1.91M	+$4.31M	+69.3%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-17
Q4 2022	-$15.1M	-$3.13M	+$3.31M	+51.4%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-13
Q3 2022	-$18.4M	-$3.72M	-$1.75M	-88.6%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-15
Q2 2022	-$16.7M	-$2.05M	-$11.3K	-0.56%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	-$16.7M	-$6.22M	-$4.97M	-396%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$11.7M	-$6.45M	-$1.6M	-32.9%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-31
Q3 2021	-$10.1M	-$1.97M	-$681K	-52.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$9.43M	-$2.04M	-$842K	-70.5%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021	-$8.59M	-$1.25M	-$81.4K	-6.95%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-16
Q4 2020	-$8.51M	-$4.85M	-$3.73M	-332%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-31
Q3 2020	-$4.78M	-$1.29M	-$174K	-15.6%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020	-$4.6M	-$1.19M	-$705K	-144%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	-$3.9M	-$1.17M	-$441K	-60.3%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-10
Q4 2019	-$3.46M	-$1.12M	+$65.9K	+5.54%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-16
Q3 2019	-$3.52M	-$1.12M	-$719K	-182%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-17
Q2 2019	-$2.81M	-$489K	+$35.6K	+6.79%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-14
Q1 2019	-$2.84M	-$731K	-$56.4K	-8.36%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-06-30
Q4 2018	-$2.78M	-$1.19M	-$837K	-237%	Oct 1, 2018	Dec 31, 2018	10-K	2020-05-15
Q3 2018	-$1.95M	-$396K	+$2.96M	+88.2%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-18
Q2 2018	-$4.91M	-$524K	-$335K	-177%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-09
Q1 2018	-$4.58M	-$674K	-$437K	-185%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-28
Q4 2017	-$4.14M	-$353K	-$142K	-67.7%	Oct 1, 2017	Dec 31, 2017	10-KT	2018-04-13
Q3 2017	-$4M	-$3.36M	-$2.76M	-462%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-14
Q2 2017	-$1.23M	-$189K	+$99.6K	+34.5%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-20
Q1 2017	-$1.33M	-$237K	+$6.37M	+96.4%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-15
Q4 2016	-$7.71M	-$210K	+$3.29M	+94%	Oct 1, 2016	Dec 31, 2016	10-KT	2018-04-13
Q3 2016	-$11M	-$598K	-$282K	-89.4%	Jul 1, 2016	Sep 30, 2016	10-KT	2018-04-13
Q2 2016	-$10.7M	-$289K	-$288K		Apr 1, 2016	Jun 30, 2016	10-Q/A	2018-03-19
Q1 2016	-$10.4M	-$6.61M	-$7.73M	-691%	Jan 1, 2016	Mar 31, 2016	10-Q/A	2018-03-19
Q4 2015	-$2.7M	-$3.5M	-$2.47M	-240%	Oct 1, 2015	Dec 31, 2015	10-Q/A	2018-03-19
Q3 2015	-$228K	-$316K			Jul 21, 2015	Sep 30, 2015	10-Q/A	2017-02-22
Q2 2015		-$1.5K^*	-$1.47K		Apr 1, 2015	Jun 30, 2015	10-Q	2015-08-19
Q1 2015		$1.12M	+$1.12M		Jan 1, 2015	Mar 31, 2015	10-Q/A	2015-06-05
Q4 2014		-$1.03M	-$1.03M		Oct 1, 2014	Dec 31, 2014	10-Q	2016-02-23
Q2 2014	-$70	-$30^*	+$19.3K		Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-19
Q1 2014	-$19.4K	-$30^*	+$20.4K		Jan 1, 2014	Mar 31, 2014	10-Q/A	2015-06-05
Q4 2013	-$39.8K	-$10^*	+$137K		Oct 1, 2013	Dec 31, 2013	10-Q	2015-04-17
Q3 2013	-$177K	$0	+$108K		Jul 1, 2013	Sep 30, 2013	10-K	2015-04-16
Q2 2013	-$285K	-$19.4K	+$226K	+92.1%	Apr 1, 2013	Jun 30, 2013	10-Q	2015-04-17
Q1 2013	-$511K	-$20.5K	+$310K	+93.8%	Jan 1, 2013	Mar 31, 2013	10-Q	2015-04-17
Q4 2012	-$822K	-$137K	+$322K	+70.1%	Oct 1, 2012	Dec 31, 2012	10-Q	2015-04-17
Q3 2012	-$1.14M	-$108K	+$310K	+74.1%	Jul 1, 2012	Sep 30, 2012	10-K	2015-04-16
Q2 2012	-$1.45M	-$245K	+$528K	+68.3%	Apr 1, 2012	Jun 30, 2012	10-Q	2015-04-16
Q1 2012	-$1.98M	-$331K	-$1.84K	-0.56%	Jan 1, 2012	Mar 31, 2012	10-Q	2015-04-16
Q4 2011	-$1.98M	-$459K	-$90.8K	-24.7%	Oct 1, 2011	Dec 31, 2011	10-Q	2015-04-16
Q3 2011	-$1.89M	-$418K			Jul 1, 2011	Sep 30, 2011	10-K	2015-04-15
Q2 2011		-$773K	-$434K	-128%	Apr 1, 2011	Jun 30, 2011	10-Q/A	2012-08-20
Q1 2011		-$329K			Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-15
Q4 2010		-$368K			Oct 1, 2010	Dec 31, 2010	10-Q	2012-02-21
Q2 2010		-$339K			Apr 1, 2010	Jun 30, 2010	10-Q/A	2011-09-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.